| abstract |
The present invention provides compounds of the Formula I: wherein R' epresents a recoverable residue of a non-steroidal anti-inflammatory drug (NSAID); and G represents a hydrolysable or metabolizable linker group; and salts, solvates, esters and prodrugs thereof, as well as pharmaceutical compositions containing them, and methods of using them to treat metabolic syndrome, dyslipidemia, cardiovascular diseases, disorders of the peripheral and central nervous system, hematological diseases, cancer, inflammation, respiratory diseases, gastroenterological diseases, diabetes, and non-alcoholic fatty liver diseases. |